NEW YORK, JANUARY 29, 2026 - Lockton Re, the reinsurance business of the world’s largest privately held independent insurance broker, is pleased to announce that Lockton Re‘s SAGE, the company’s proprietary analytics platform has been awarded another US Patent for systems and methods for custom and real-time visualization, comparison, and analysis of insurance and reinsurance structures, with additional patents pending.
“Lockton Re’s SAGE was inspired by our clients, who desired better analytics to support more informed risk transfer decisions. The unique software optimizes efficient decision-making, offering our clients flexibility, deep insights, and financial benefits,” said Adam Troyer, Global Head of Analytics, Lockton Re.
The key features of the platform enable clients to make faster, more informed decisions, providing unprecedented transparency and efficiency.
Claude Yoder, Chief Digital Officer at Lockton, commented on the new patent, “Analytics has been central to Lockton Re's value since its inception in 2019, and Lockton Re’s SAGE has been on the cutting edge of what is possible ever since.”
With data transformed into real-time financial results for risk transfer decision making, the platform allows clients to visualize, design, and modify different structures to help optimize risk portfolios. Built on a modern stack with a future-ready framework, Lockton Re’s SAGE has and will continue to catalyze growth across the entire marketplace.
“Lockton Re’s SAGE platform stands out for supporting clients as data and analytics become increasingly vital within the (re)insurance industry. Securing our latest US software patent is a testament to the pioneering spirit of our Global Analytics team and our autonomy as an independent organization. The power of our independence allows us to prioritize the digital initiatives that deliver the most significant returns for our clients, and that legacy-bound organizations simply cannot match,” added Claude Yoder.
Lockton Re’s rapid innovation cycle has yielded three US patents in three years. This trend is set to continue as the organization advances a significant slate of additional patents through the pending stage.
